StocksMedium•17 November 2026•
1 min read
SELLAS Life Sciences Launches $150 Million Public Offering of Common Stock
Key Facts
1SELLAS Life Sciences announced the commencement of an underwritten public offering of $150.0 million of its common stock.
2The company intends to grant underwriters a 30-day option to purchase up to an additional $22.5 million of shares.
SELLAS Life Sciences announced the commencement of an underwritten public offering of $150.0 million of its common stock. GlobeNewswire reported that the company intends to grant underwriters a 30-day option to purchase up to an additional $22.5 million of shares under the same terms and conditions.
The company is seeking to raise these funds for the clinical development of cancer therapies and general corporate purposes. SLS closed at $7.47 on November 16, 2026, having reached a day high of $8.39 and a low of $7.24 during that session.